Stay updated on CHF 6333 Safety in CF and NCFB Clinical Trial
Sign up to get notified when there's something new on the CHF 6333 Safety in CF and NCFB Clinical Trial page.

Latest updates to the CHF 6333 Safety in CF and NCFB Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated to v3.3.2 from v3.3.1 with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.3.1 updates the page from v3.2.0, reflecting a new version in the metadata. This minor update does not affect study details or content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page no longer displays a government funding/operating status notice. The core study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedThe screenshots show only minor UI adjustments to the Study Details page, such as layout/typography changes, with no changes to core content like eligibility criteria, study design, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check79 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. Overall, the page now emphasizes a new version label while trimming substantive drug-related content.SummaryDifference0.4%

Stay in the know with updates to CHF 6333 Safety in CF and NCFB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHF 6333 Safety in CF and NCFB Clinical Trial page.